Vicki L. Sato

Insider Reports History

Location
Waltham, MA
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vicki L. Sato:

Form 4 holding Director

Denali Therapeutics Inc.

Security class
Common Stock
Shares / value
107,976
Estimated value
$2,257,778
Report date
02 Jan 2025
Price
$20.91
Ownership
Direct
Form 4 holding Director

Vir Biotechnology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
$24,480
Report date
24 Feb 2026
Price
$1.53
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Denali Therapeutics Inc.

Security class
Stock Option (right to buy)
Shares / value
17,901
Estimated value
Report date
31 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Akouos, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
01 Dec 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Vicki L. Sato

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .